AML Treatment Combo Shows Major Promise

Just saw this study where they combined venetoclax with the classic 3+7 chemo for newly diagnosed AML patients, and the results are wild—over 80% complete response rate! They tried different lengths for the venetoclax part (8, 11, or 14 days) and didn’t see much difference, so shorter might be just as good. Super hopeful for people facing AML right now! #Leukemia #CancerResearch #MedicalBreakthrough #Hematology #Health